Night pharmacokinetics of single dosage theophylline: comparison of three drugs in similar conditions
Abstract
We have carried out a stead y state pharmacokynetic comparison of three different theophylline preparations in nine healthy volunteers using a once a day dosage schedule of 600 mg theophylline given before bedtime for four days. The preparations tested were Retafyllin 200 mg depot tablet (R), Theo-Dur 200 mg depot tablet (T) and Uniphyllin 200 mg tablet (U). All preparations in steady state reached the serum level of 8.9— 10.2 microg/ml after a single evening dose of theophylline 600 mg. The pharmacokinetic profile of these slow release theophylline preparations was such that there is no risk of exceeding the therapeutic range even after a rather high evening dose. Individual variation was also observed in the present study but nobody exceeded the therapeutic range. The pharmacokinetic profiles of R and U were quite similar and they seemed to have suitable pharmacokinetic properties for once a day dosage, and they showed a more sustained action than T. Only minimal gastrointestinal side effects were reported during this study.
About the Authors
P. KarttunenFinland
H. Tukiainen
Finland
S. Nykanen
Finland
V. Saano
Finland
References
1. Barnes Р. J., Greening А. P., Neville L. et al. / / Lancet 1982.—Vol. 1.—P. 299.
2. Elenbaas R. М., Massoud N. / / Pharmacokinetic basis for drug treatment.—New York, 1984.—P. 82—84.
3. Hendeles L., Iafrate R. P., Weinberger M. / / Clin. Pharm aco kinet.—1984 , - Vol. 9.—P. 95.
4. Jatlow P. / / Clin. Chem .—1975.—Vol. 21.—P. 1518.
5. Jonkman J. H. G., Berg W. C., de Zeeuw R. A. Sustained release theophylline, a biopharm aceutical challenge to a clinical need.—E xcerpta Medica, Amsterdam , Oxford, Princeton.—1983.—P. 156—158.
6. Jonkman J. H. G., van der Boon W. J. V., Balant L. B. et al. / / Eur. J. Clin. Pharmacol.—1984.—Vol. 26.—P. 215.
7. Kyle G. M., Smolensky M. H., Thorne L. G. et al. / / Recent advantages in the chronobiology of allergy and immunology. — Oxford, 1980,—P. 186.
8. Kyle G. M., Smolensky M. H., Thorne L. G., McGovern J. P. /, Recent advantages in the chronobiology of allergy and Immunology.—Oxford, 1980.—P. 558.
9. Lesko L. J., Brousseau D., Canada A. T., Eastwood G. / / J. Pharm . Sci.—1980.—Vol. 69.—P. 358.
10. MacLeod S., Isles A., Levinson H., Thiessen J. / / Sustained release theophylline, a biopharm aceutical challenge to a clinical need.—Excerpta Medica, Amsterdam , Oxford, Princeton .—1983.—P. 454—457.
11. Milledge J. S., Morris J. / / J. Int. Med. Res.—1979.—Vol. 7, Supp l.—P. 106.
12. Osman M. A ., Patel R. B., Welling P. G. Sustained release theophylline, a biopharm aceutical challenge to a clinical Need.—Excerpta Medica, Amsterdam , Oxford, Princeton .—1983.—P. 99—102.
13. Scheffe H. The analyses of varian ce.—New York, 1959.
14. Scott P. H., Tabachnik E., McLeod S. et al. / / J. Pediatr.1981.—Vol. 99.—P. 476.
15. Taylor D. R., Kinney C. D., McDevitt D. / / Br. J. Clin. Pharmacol.—1983.—Vol. 16.—P. 511.
16. Taylor D. R., Kinney C. D., McDevitt D. / / Br. J. Clin. Pharmacol.—1984.—Vol. 17.—P. 15.
Review
For citations:
Karttunen P., Tukiainen H., Nykanen S., Saano V. Night pharmacokinetics of single dosage theophylline: comparison of three drugs in similar conditions. PULMONOLOGIYA. 1991;(3):28-32. (In Russ.) https://doi.org/617.234.015